ORMP (oramed.com) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Oramed Pharmaceuticals Inc. (ORMP)

This daily chart from the GURU.Markets service illustrates the future P/E ratio for Oramed Pharmaceuticals (ORMP), where the 0.00 mark captures this metric. The company is currently reviewing its assets following unsuccessful trials while maintaining margins at previous levels. The innovative POD technology enables the creation of oral insulin tablets by protecting the protein in the stomach. However, a capital shortage and the risk of failure for key developments pose serious threats to the business's survival.

Oramed Pharmaceuticals - Rasio kapitalisasi marang bathi mangsa ngarep ORMP (periode 04.07.2022 - 12.11.2026)

Ringkesan rincian data analitis Oramed Pharma (ORMP)

- rega saiki lan proyeksi nilai saham:
Kutipan saham Oramed Pharmaceuticals|ORMP - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Nilai pasar Oramed|ORMP - Total Nilai Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi saben Saham Oramed Pharmaceuticals|ORMP - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku oramed.com|ORMP - Nilai Agregat Aset
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Oramed Pharmaceuticals|ORMP - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Oramed Pharmaceuticals|ORMP - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Oramed|ORMP - Utang jangka dawa|Utang jangka cendhak perusahaan Oramed Pharmaceuticals|Rasio cepet oramed.com
- rincian asil keuangan lan kelipatan valuasi:
ORMP - Bathi resik|Bathi sing dikarepake Oramed Pharmaceuticals|ORMP - Koefisien rega marang bathi|Pangali Forward P/E Oramed Pharmaceuticals|ORMP - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Oramed|ORMP - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Oramed Pharmaceuticals|ORMP - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan oramed.com|ORMP - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Oramed Pharmaceuticals
Pambiji fundamental:ORMP Oramed Pharmaceuticals Inc.
Produk merek Oramed Pharmaceuticals

Fundamental asset screening requires analyzing the ratio of market capitalization to expected earnings, which allows for an assessment of whether a security is overbought or undervalued. The trend of the forward P/E for Oramed Pharmaceuticals (ORMP) reflects analyst consensus forecasts, where a decreasing multiple enhances the resilience of ORMP quotes against market shocks amid the development of a revolutionary oral insulin delivery platform.

Pesaing Oramed Pharmaceuticals (ORMP)

Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Amphastar Pharmaceuticals, Inc. AMPH|Pacira Pharmaceuticals (PCRX) - Rasio prakiraan rega marang bathi|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Corp)|AQST: Pangali Forward P/E|scPharmaceuticals (SCPH) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Tectonic Therapeutic Inc.|Prakiraan rega marang bathi Tonix Pharma (TNXP)|Pangali Forward P/E SXTC|EPRX - Rasio prakiraan rega marang bathi|Pangali Forward P/E BHST (BioHarvest Sciences)|EXOZ: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma Inc (ABVC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake CPIX (Cumberland Corp)|QNTM (Quantum BioPharma Ltd) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E ranitherapeutics.com (RANI)|Rega marang bathi mangsa ngarep Synergy CHC SNYR|Pangali mangsa ngarep rega marang bathi RLYB|LEXX - Rega marang bathi mangsa ngarep|pulmatrix.com (PULM) - Prakiraan rega marang bathi|PTHL: Pangali Forward P/E|Aptorum Group (APM) - Pangali Forward P/E|LYRA (Lyra Therapeutics, Inc) - Pangali Forward P/E|Prakiraan rega marang bathi Impact BioMedical, Inc. (IBO)|Pangali Forward P/E TNFA|YCBD - Rasio prakiraan rega marang bathi|PainReform - Prakiraan rega marang bathi|Pangali Forward P/E Altamira Therapeutics Ltd CYTO|LIPO: Prakiraan rega marang bathi|OptiNose Corp - Rasio kapitalisasi marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharmaceuticals, Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Qilian International Holding Group (QLI)|Pangali Forward P/E SLRN|Pangali Forward P/E TFF Pharmaceuticals, Inc (TFFP)